Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

CUSIP: 03615A108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19,607,843
Total 13F shares
1,811,877
Share change
-274,983
Total reported value
$3,929,691
Put/Call ratio
95%
Price per share
$2.17
Number of holders
42
Value change
-$326,377
Number of buys
22
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 03615A108?
CUSIP 03615A108 identifies ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q2 2025

As of 30 Jun 2025, Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,811,877 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Merit Financial Group, LLC, MARSHALL WACE, LLP, BlackRock, Inc., NORTHERN TRUST CORP, Greenwich Wealth Management LLC, Wescott Financial Advisory Group, LLC, and STATE STREET CORP. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.